On Friday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened higher 3.94% from the last session, before settling in for the closing price of $1.27. Price fluctuations for SLS have ranged from $0.50 to $1.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 22.63% annually for the last half of the decade. Company’s average yearly earnings per share was noted 60.45% at the time writing. With a float of $70.08 million, this company’s outstanding shares have now reached $70.38 million.
In an organization with 16 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 0.43%, while institutional ownership is 7.63%.
SELLAS Life Sciences Group Inc (SLS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.25 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.03) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 60.45% per share during the next fiscal year.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 2.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.12 million. That was better than the volume of 1.07 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 58.67%. Additionally, its Average True Range was 0.08.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 67.09%, which indicates a significant decrease from 72.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.13% in the past 14 days, which was higher than the 51.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2304, while its 200-day Moving Average is $1.2191. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.3630. Second resistance stands at $1.4060. The third major resistance level sits at $1.4625. If the price goes on to break the first support level at $1.2635, it is likely to go to the next support level at $1.2070. The third support level lies at $1.1640 if the price breaches the second support level.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 64,332K shares outstanding in the company with a market cap of 96.56 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,470 K.
